Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer.
Publication
, Preprint
Lim, BJW; Liu, M; Wang, L; Kong, SLY; Yin, T; Yan, C; Xiang, K; Cao, C; Wu, H; Mihai, A; Tay, FP-L; Wang, E; Jiang, Q; Ma, Z; Tan, L ...
February 2, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Lim, B. J. W., Liu, M., Wang, L., Kong, S. L. Y., Yin, T., Yan, C., … Li, Q.-J. (2025). Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. https://doi.org/10.1101/2025.01.29.635356
Lim, Bryan Jian Wei, Mingyong Liu, Liuyang Wang, Sharleen Li Ying Kong, Tao Yin, Chengsong Yan, Kun Xiang, et al. “Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer.,” February 2, 2025. https://doi.org/10.1101/2025.01.29.635356.
Lim BJW, Liu M, Wang L, Kong SLY, Yin T, Yan C, et al. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2025.
Lim, Bryan Jian Wei, et al. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2 Feb. 2025. Pubmed, doi:10.1101/2025.01.29.635356.
Lim BJW, Liu M, Wang L, Kong SLY, Yin T, Yan C, Xiang K, Cao C, Wu H, Mihai A, Tay FP-L, Wang E, Jiang Q, Ma Z, Tan L, Chia RN, Qin D, Pan CC, Wang X-F, Li Q-J. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2025.